Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
PACIRA RG (NQ: PCRX)
38.05 USD  +0.85 (+2.28%)
Official Closing Price  /  Updated: 5:20 PM EDT, Jun 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 507,702
Open 37.05
Bid (Size) 37.65 (100)
Ask (Size) 39.25 (100)
Prev. Close 37.20
Today's Range 36.55 - 38.15
52wk Range 26.95 - 51.10
Shares Outstanding 40,732,255
Dividend Yield N/A
Performance
YTD
-17.82%
-17.82%
1 Month
+11.42%
+11.42%
3 Month
+24.04%
+24.04%
6 Month
-10.58%
-10.58%
1 Year
-14.78%
-14.78%
Top News
More News
Pacira Pharmaceuticals and Nuance Biotech Announce License Agreement for EXPAREL® in China
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) and Nuance Biotech Co. Ltd (Nuance) today announced that they have entered into an agreement with Nuance, a China based specialty pharmaceutical company, to... Read More
from GlobeNewswire News Releases
Consolidated Research: 2018 Summary Expectations for Microchip Technology, New Jersey Resources, Brown-Forman, Pacira Pharmaceuticals, Team, and Solaris Oilfield Infrastructure — Fundamental Analysis,
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Microchip Technology... Read More
from GlobeNewswire News Releases
More News
Read More
Aetna DocFind Directory Now Highlights Providers Offering Opioid Alternatives, Including EXPAREL®
from GlobeNewswire News Releases
Pacira Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
from GlobeNewswire News Releases
MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean Surgery (ERACS™) Collaborative to Minimize Opioid Use
from Business Wire News Releases
Pacira Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results
from GlobeNewswire News Releases
Pacira Pharmaceuticals to Present at Two Healthcare Conferences in May
from GlobeNewswire News Releases
Pacira Pharmaceuticals Announces Timing for First Quarter 2018 Financial Results Webcast and Conference Call
from GlobeNewswire News Releases
Noteworthy Monday Option Activity: LE, FDC, PCRX
category Stocks
from Market News Video
Pacira Pharmaceuticals (PCRX) Shares Cross Above 200 DMA
category Stocks
from Market News Video
Look Under The Hood: IHE Has 25% Upside
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.